On February 8, 2010
SEC Probe Into Dendreon Cancer Drug “Conspiracy” Could Put Rumors to Rest
The SEC’s Office of the Inspector General will investigate allegations that Dendreon (DNDN) stock was manipulated in an infamous “bear raid” last April. The probe is an opportunity to put to rest one of the more bizarre chapters in cancer
…
0 Comments